Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06444178
Status:
RECRUITING
Last Update Posted:
2024-06-05
First Post:
2024-05-30
Brief Title:
Assessment of Gastrointestinal Blood Loss After Receiving Aspirin or Aspirin Plus Rivaroxaban or Aspirin Plus REGN9933 or Aspirin Plus REGN7508 in Healthy Adult Participants
Sponsor:
Regeneron Pharmaceuticals
Organization:
Regeneron Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-10-04
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-04-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-07-02
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-30
First Submit QC Date:
May 30 2024
Study First Post Date:
2024-06-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-07
Last Update Post Date:
2024-06-05
Last Update Post Date Type:
ACTUAL